Bulgarian doctors cured in 5 days patients with COVID-19 with a new pill – Medicines

–

He is only 34 years old, but is already a lecturer at the Medical University in Pleven, Nova TV reports.

The EMA begins a real-time review of Merck’s COVID pill

He graduated in medicine nine years ago. In March he defended his scientific degree in medicine. He is an anesthesiologist at the Pleven Gynecological Hospital, which is the largest center in Bulgaria for experimental application of a pill that treats coronavirus.

Dr. Malkodanski is responsible for the study of the drug, developed by a large pharmaceutical company.

“They contacted me and offered me to participate as a principal investigator. After getting acquainted with the drug and its side effects, I agreed to use it and I do not regret it, because the results are really good. For the first time we use a drug that works against the coronavirus. It is associated with the destruction of the virus enzyme. It is taken for five days “, the doctor explained.

The participants in the experiment were two men and a woman. All are about 40 years old, whose identity is kept secret.

“All three patients are mine. They know it is an experimental treatment and they know all the risks. A declaration of consent is signed. The patient receives tablets for five days. He receives them morning and evening. We follow the protocol of the pharmaceutical company. The cured are very well. They took him out. All three patients are mine. They know it is an experimental treatment and they know all the risks. A declaration of consent is signed. The patient receives tablets for five days. He receives them morning and evening. We follow the protocol of the pharmaceutical company. The cured are very well. They made it easy, “the specialist explained.

The age limit is standard – it is experimented with people aged 18 to 60 years. “Patients must have criteria in order to enter counter-criteria. One of them is a high body mass with an index over 35. The main thing that is observed is that there is no progression of the disease.

“Their symptoms initially subsided and they completed their 14-day quarantine without any problems,” said Dr. Malkodanski.

Such experimental treatment is performed in a total of 12 countries with 4 centers in each of them. The results so far are more than optimistic. The drug does not yet have a name. For Dr. Malkodanski, this experiment will leave a lasting mark in the history of world medicine. It is not yet clear when people will have free access to the drug.